Article Details

Vor Biopharma: Promising Clinical Data and Strategic Advancements Support Buy Rating

Retrieved on: 2024-09-07 03:34:37

Tags for this article:

Click the tags to see associated articles and topics

Vor Biopharma: Promising Clinical Data and Strategic Advancements Support Buy Rating. View article details on hiswai:

Excerpt

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Vor Biopharma (VOR – Research Report) today and set a price targ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up